Intranasal vaccination against the gut pathogen norovirus showed protection against gastroenteritis and other disease complications as well as production of dose-dependent IgG and IgA memory B-cells in peripheral blood [47, 48]. This evidence concerns the gene CD79A and gastroenteritis.